Rabu, 26 Maret 2014

Hepatitis C drug Sovaldi is priced $1000 per pill, $84,000 per Course!


The U.S. lawmakers have inquired Gilead Chief Executive John C. Martin about the high cost of its new Hepatitis C drug Sovaldi, which is priced $1000 per pill, $84,000 per course!
Gilead Sciences, a biotechnology company has manufactured a new drug called “Sovaldi” for Hepatitis C. According to the company, the drug will cost $1000 per pill, so the amount of pills required for a complete course

Tidak ada komentar:

Posting Komentar